Ardelyx, Inc.
General ticker "ARDX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.2B (TTM average)
Ardelyx, Inc. follows the US Stock Market performance with the rate: 31.3%.
Estimated limits based on current volatility of 2.6%: low 5.63$, high 5.93$
Factors to consider:
- Total employees count: 395 as of 2024
- US accounted for 95.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Strategic risks and growth management, Labor/talent shortage/retention, Regulatory and compliance, Litigation risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.63$, 5.94$]
- 2025-12-31 to 2026-12-31 estimated range: [2.45$, 5.51$]
Financial Metrics affecting the ARDX estimates:
- Positive: with PPE of -29.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -3.92 <= 0.33
- Positive: -4.48 < Investing cash flow per share per price, % of -1.60
- Positive: Interest expense per share per price, % of 1.76 <= 3.41
- Positive: 18.93 < Shareholder equity ratio, % of 39.77 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
Short-term ARDX quotes
Long-term ARDX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $52.16MM | $124.46MM | $333.62MM |
| Operating Expenses | $115.92MM | $187.73MM | $361.56MM |
| Operating Income | $-63.76MM | $-63.28MM | $-27.95MM |
| Non-Operating Income | $-3.44MM | $-2.24MM | $-10.92MM |
| Interest Expense | $3.40MM | $8.87MM | $20.09MM |
| R&D Expense | $35.20MM | $35.54MM | $52.32MM |
| Income(Loss) | $-67.20MM | $-65.52MM | $-38.87MM |
| Taxes | $0.01MM | $0.55MM | $0.27MM |
| Profit(Loss)* | $-67.21MM | $-66.07MM | $-39.14MM |
| Stockholders Equity | $98.33MM | $166.82MM | $173.29MM |
| Inventory | $3.28MM | $12.45MM | $21.17MM |
| Assets | $190.07MM | $297.58MM | $435.75MM |
| Operating Cash Flow | $-70.04MM | $-89.72MM | $-44.81MM |
| Capital expenditure | $0.06MM | $0.34MM | $1.01MM |
| Investing Cash Flow | $18.41MM | $-131.25MM | $-18.32MM |
| Financing Cash Flow | $75.34MM | $146.29MM | $106.59MM |
| Earnings Per Share** | $-0.42 | $-0.30 | $-0.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.